fda warning letters compounded semaglutide tirzepatide 2025 National Hispanic Medical Association | After GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA warns against compounded GLP-1

2018;67(Suppl 3):S431-s9

However, medical outcomes are heavily dependent on how consistently a patient can follow the required administration rules

What is Mounjaro for Adults with Type 2 Diabetes | Mounjaro ( tirzepatide)

In the short term, the Centers for Medicare and Medicaid Services, the federal agency that administers Medicare and partners with state governments to manage Medicaid, is testing what would happen if Medicare Part D covered GLP-1s for obesity to get a sense for how much it would cost, and what those positive externalities might be

She and our support team will create and guide a personalized plan designed for safe, sustainable results